HopeStage
Back to all studies
Enrolling By InvitationNCT06916403

Safety and Efficacy of Ketamine Intravenous Infusions in the Treatment of Fibromyalgia

Observational studyAges 18+CanadaDepression
The study in practice

Understand this study

Who could participate?

Listed age limits: from 18 years.

Listed locations
ThornhillSee all locations and recruitment

Get this study by email

HopeStage may email me about this study.
Loading the security check...

What to know before participating

A point to clarify

This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?

Study clarity

Things to check before joining

Study start dateStarted: November 30, 2020
Recruitment status
Enrolling By Invitation
Enrollment listed in the registry
50
Sponsor
Wilderman Medical Clinic
Sponsor type
Hospital / academic medical center
Study type
Observational
Intervention type
Drug
Locations
Canada
Age range
Over 18 Years
Official registry ID
NCT06916403
Official title
Show the full official title

A Two-part Study to Access the Safety and Efficacy of Ketamine Intravenous Infusions in the Treatment of Fibromyalgia

Recruitment & locations

By invitation

Thornhill

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is Wilderman Medical Clinic, a hospital or academic medical center.

Does this study involve medication?

Yes. The study involves medication, including Intravenous Ketamine Infusions.

Who can participate?

Listed age limits: from 18 years.

Is this study still recruiting?

The registry lists this study as enrolling by invitation.

Want to explore more studies?

Explore studies